0001759778-21-000003.txt : 20210526
0001759778-21-000003.hdr.sgml : 20210526
20210526162028
ACCESSION NUMBER: 0001759778-21-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210526
DATE AS OF CHANGE: 20210526
EFFECTIVENESS DATE: 20210526
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pattern Pharma Inc.
CENTRAL INDEX KEY: 0001759778
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-400781
FILM NUMBER: 21966253
BUSINESS ADDRESS:
STREET 1: 31 RIDGE DR.
CITY: TORONTO
STATE: A6
ZIP: M4T 1B6
BUSINESS PHONE: 416-302-5155
MAIL ADDRESS:
STREET 1: 31 RIDGE DR.
CITY: TORONTO
STATE: A6
ZIP: M4T 1B6
D
1
primary_doc.xml
X0708
D
LIVE
0001759778
Pattern Pharma Inc.
31 RIDGE DR.
TORONTO
A6
ONTARIO, CANADA
M4T 1B6
416-302-5155
ONTARIO, CANADA
None
None
Corporation
true
2018
Mark
Frans
van Coeverden de Groot
31 RIDGE DR.
TORONTO
A6
ONTARIO, CANADA
M4T 1B6
Executive Officer
Director
Andrew
Williams
31 RIDGE DR.
TORONTO
A6
ONTARIO, CANADA
M4T 1B6
Executive Officer
Hans
Kierstead
31 RIDGE DR.
TORONTO
A6
ONTARIO, CANADA
M4T 1B6
Director
Nick
Glover
31 RIDGE DR.
TORONTO
A6
ONTARIO, CANADA
M4T 1B6
Executive Officer
Pharmaceuticals
No Revenues
- 06b
false
2021-05-14
true
true
true
true
This Special Equity Right Certificate represents the right for the investment to automatically convert into shares of the Issuer in a subsequent offering until April 30, 2024.
false
0
150000
150000
0
false
1
0
0
0
In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors.
false
Pattern Pharma Inc.
Mark van Coeverden de Groot
Mark van Coeverden de Groot
CEO
2021-05-26